0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

The Autocrine Function of Vasoactive Intestinal Peptide on Human Neuroblastoma Cell Growth and Differentiation

Jeffrey C. Pence, MD; Nicholas A. Shorter, MD
Arch Surg. 1993;128(5):591-595. doi:10.1001/archsurg.1993.01420170127020.
Text Size: A A A
Published online

• Direct associations between serum concentrations and immunohistochemically detectable vasoactive intestinal peptide (VIP) and maturing neuroblastoma have been documented. Furthermore, VIP has been shown to induce both the growth inhibition and morphological differentiation of cultured human neuroblastoma cell lines. As such, it is hypothesized that VIP may be operative in the autocrine regulation of neuroblastic growth and differentiation. To test this hypothesis, VIP-induced differentiation of human neuroblastoma LA-N-5 cells was performed. Significant concomitant increases in both intracellular and extracellular VIP concentrations were observed. In addition, a marked increase in VIP receptor expression was demonstrated with VIP-induced cellular differentiation. Receptor function was maintained with enhanced expression, as evidenced by an increase in the generation of intracellular cyclic adenosine monophosphate in response to exogenous VIP stimulation. Concomitant enhancement of both intracellular and extracellular VIP expression, coupled with the induction of functional specific VIP receptors during VIP-induced differentiation, provides critical evidence for the autocrine regulation of neuroblastoma maturation by this peptide.

(Arch Surg. 1993;128:591-595)

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();